Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Antacids on Gleevec® in Healthy Volunteers
This study has been completed.
Study NCT00446316   Information provided by University of Pittsburgh

First Received on March 8, 2007.   Last Updated on April 28, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Antacids (Mg-Al-based)
Imatimib Mesylate (Gleevec®)
Additional drug interventions recognized in this trial
Aluminum Hydroxide
Aluminum hydroxide, magnesium hydroxide, drug combination
Antacids
Anti-Ulcer Agents
Imatinib
Magnesium Hydroxide
More general drug interventions related to this trial
Adjuvants, Immunologic
Antineoplastic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University of Pittsburgh
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services